This application proposes to investigate the mediating role of endocrine consequences on the occurrence of mental health outcomes that take place among HIV-1+ IDUs. Injecting drug use (IDU) is one of the major risk factors for contracting human-immunodeficiency virus, type-i, (HIV-1) infection. abnormalities in various endocrine systems develop in IDUs and HIV-1+IDUs and may be associated with number of mental health outcomes. Our earlier reports show that the ACTH and cortisol responses to a cold pressor challenge are attenuated in HIV-1 + individuals and, thus, support the proposed hypothesis. An array of outcomes including, anxiety, depression, and perceived psychological distress and difficulty adapting to stressors occurs in HIV-1 + IDUs. Since HIV is present in the brain soon after infection and esides in very high concentrations in the hippocampus, it is proposed that different endocrine systems are likely to be adversely impacted centrally in HIV-1 infection. It is important to understand the mechanisms involved in the development of neuroendocrine abnormalities - central or peripheral - in order to intervene n mental health-related problems. This five-year proposal investigates the responses of the thyroid and gonads to trophic hormones, hyroid releasing hormone (TRH), and luteinizing hormone-releasing hormone (LHRH), as well as adrenal Aictivity in response to a low-dose ACTH challenge. This investigation will be carried out using a crossectional three-group design (HIV-i+ lDUs, N+1OO, HIV-1- IDUs, N=100, and HIV-1- non-IDUs, N=100) with the total N = 300, X 3 ethnicitlies (African-Americans, Hispanics, Caucasians) X 2 genders (Women and Men). Only those HIV seropostiive subjects who do not have AIDS-defining symptoms and are not being treated with triple-drug therapy will be enrolled since the effect of triple-drug therapy on the endocrine system is unknown at this time. It is proposed to investigate whether the endocrine responses nediate mental health outcomes (i.e., depression, anxiety, and perceived psychological distress). These data will be useful in designing suitable interventions.

National Institute of Health (NIH)
National Institute on Drug Abuse (NIDA)
Research Project (R01)
Project #
Application #
Study Section
AIDS and Related Research 8 (AARR)
Program Officer
Khalsa, Jagjitsingh H
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Miami School of Medicine
Schools of Medicine
United States
Zip Code
Jones, Deborah L; Waldrop-Valverde, Drenna; Gonzalez, Peggy et al. (2010) Mental health in HIV seronegative and seropositive IDUs in South Florida. AIDS Care 22:152-8
Ownby, Raymond L; Kumar, Adarsh M; Benny Fernandez, J et al. (2009) Tumor necrosis factor-alpha levels in HIV-1 seropositive injecting drug users. J Neuroimmune Pharmacol 4:350-8
Kumar, Adarsh M; Fernandez, J B; Singer, Elyse J et al. (2009) Human immunodeficiency virus type 1 in the central nervous system leads to decreased dopamine in different regions of postmortem human brains. J Neurovirol 15:257-74
Waldrop-Valverde, Drenna; Jones, Deborah L; Weiss, Stephen et al. (2008) The effects of low literacy and cognitive impairment on medication adherence in HIV-positive injecting drug users. AIDS Care 20:1202-10
Georgiou, Michalis F; Gonenc, Ati; Waldrop-Valverde, Drenna et al. (2008) Analysis of the effects of injecting drug use and HIV-1 infection on 18F-FDG PET brain metabolism. J Nucl Med 49:1999-2005
Kumar, Adarsh M; Borodowsky, Irina; Fernandez, Benny et al. (2007) Human immunodeficiency virus type 1 RNA Levels in different regions of human brain: quantification using real-time reverse transcriptase-polymerase chain reaction. J Neurovirol 13:210-24
Waldrop-Valverde, Drenna; Ownby, Raymond L; Wilkie, Frances L et al. (2006) Neurocognitive aspects of medication adherence in HIV-positive injecting drug users. AIDS Behav 10:287-97
Waldrop-Valverde, Drenna; Ownby, Raymond L; Kumar, Mahendra (2005) Influence of depression and HIV serostatus on the neuropsychological performance of injecting drug users. Psychiatry Clin Neurosci 59:372-8
Kumar, Adarsh M; Solano, Maria P; Fernandez, Jesus B et al. (2005) Adrenocortical response to ovine corticotropin-releasing hormone in young men: cortisol measurement in matched samples of saliva and plasma. Horm Res 64:55-60
Waldrop-Valverde, Drenna; Valverde, Eduardo (2005) Homelessness and psychological distress as contributors to antiretroviral nonadherence in HIV-positive injecting drug users. AIDS Patient Care STDS 19:326-34

Showing the most recent 10 out of 13 publications